PMC5337345_01
TTE revealing the mass on the pulmonary valve.
CRICC2017-6263578.001.jpg
PMC5337345_01_CRICC2017-6263578.001.jpg
fig1
At day 4, TTE revealed signs of pulmonary hypertension (systolic PAP at 50 mmHg + CVP) and a mass (2 x 3 cm) located on the pulmonary valve, causing moderate pulmonary valve insufficiency estimated at 1.5/4 (Figure 1).
With the TEE on Doppler mode, we can estimate the tumour's blood flow obstruction in the pulmonary artery.
CRICC2017-6263578.002.jpg
PMC5337345_01_CRICC2017-6263578.002.jpg
fig2
At this moment, a new (TEE) showed that mass on the pulmonary valve almost completely obstructed the blood flow in the pulmonary artery (Figure 2).
On the CT scan, the tumour is evaluated at 38.8 mm x 43.5 mm.
CRICC2017-6263578.003.jpg
PMC5337345_01_CRICC2017-6263578.003.jpg
fig3
It also revealed the presence of a noncompressive pericardial effusion (Figures 3 and 4).
Illustration of the tumour's heterogeneity in contrast uptake.
CRICC2017-6263578.004.jpg
PMC5337345_01_CRICC2017-6263578.004.jpg
fig4
It also revealed the presence of a noncompressive pericardial effusion (Figures 3 and 4).